Breast cancer histopathology is predictive of low-risk Oncotype Dx recurrence score.
Wilson, Parker C. MD, PhD *,1; Chagpar, Anees B. MD, MBA, MPH 2; Cicek, Ali F. MD 1; Bossuyt, Veerle MD 1; Buza, Natalia MD 1; Mougalian, Sarah MD 3; Killelea, Brigid K. MD, MPH 2; Patel, Natalie MD 1; Harigopal, Malini MD 1
[Article]
Breast Journal.
24(6):976-980, November/December 2018.
(Format: HTML, PDF)